Roy Furman

739 total citations
18 papers, 574 citations indexed

About

Roy Furman is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Roy Furman has authored 18 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Roy Furman's work include Neuroscience and Neuropharmacology Research (8 papers), Ion channel regulation and function (7 papers) and Photoreceptor and optogenetics research (4 papers). Roy Furman is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Ion channel regulation and function (7 papers) and Photoreceptor and optogenetics research (4 papers). Roy Furman collaborates with scholars based in United States. Roy Furman's co-authors include J. C. Tanaka, Robert L. Barchi, Donna Glover, W. Michael Hogan, Joan E. Mollman, Jacqueline C. Tanaka, John F. Eccleston, Paul Müeller, Karen Aspry and Jerome D. Cohen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Diabetes Care and Biochemistry.

In The Last Decade

Roy Furman

18 papers receiving 558 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roy Furman United States 13 320 244 121 78 58 18 574
Thomas Griesbacher Austria 15 256 0.8× 191 0.8× 82 0.7× 28 0.4× 123 2.1× 38 714
H Rivera United States 11 403 1.3× 99 0.4× 68 0.6× 62 0.8× 44 0.8× 21 664
Shoichiro Takata Japan 13 316 1.0× 145 0.6× 53 0.4× 186 2.4× 62 1.1× 21 606
Raphaël Rapetti‐Mauss France 12 384 1.2× 86 0.4× 29 0.2× 71 0.9× 32 0.6× 18 524
Sandra R. Brave United Kingdom 10 213 0.7× 140 0.6× 74 0.6× 46 0.6× 29 0.5× 13 562
Shinichi Ito Japan 12 140 0.4× 51 0.2× 64 0.5× 55 0.7× 55 0.9× 48 422
Sara Monaco Italy 8 258 0.8× 40 0.2× 57 0.5× 132 1.7× 45 0.8× 8 470
W Schmidt Germany 14 202 0.6× 227 0.9× 136 1.1× 22 0.3× 238 4.1× 41 615
Danilo Croci Italy 17 265 0.8× 66 0.3× 318 2.6× 34 0.4× 28 0.5× 24 902
Eugène Cox United States 12 154 0.5× 79 0.3× 182 1.5× 19 0.2× 38 0.7× 22 623

Countries citing papers authored by Roy Furman

Since Specialization
Citations

This map shows the geographic impact of Roy Furman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Furman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Furman more than expected).

Fields of papers citing papers by Roy Furman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy Furman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Furman. The network helps show where Roy Furman may publish in the future.

Co-authorship network of co-authors of Roy Furman

This figure shows the co-authorship network connecting the top 25 collaborators of Roy Furman. A scholar is included among the top collaborators of Roy Furman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy Furman. Roy Furman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Shao, Hui, Vivian Fonseca, Roy Furman, Luigi Meneghini, & Lizheng Shi. (2020). Impact of Quality Improvement (QI) Program on 5-Year Risk of Diabetes-Related Complications: A Simulation Study. Diabetes Care. 43(11). 2847–2852. 10 indexed citations
2.
Baz, Rachid, et al.. (2020). Quality Improvement at an Academic Cancer Center: Venous Thromboembolism Prophylaxis in Patients With Multiple Myeloma. Cancer Control. 27(2). 1148365468–1148365468. 1 indexed citations
3.
Shao, Hui, Lizheng Shi, Roy Furman, et al.. (2019). 174-LB: Impact of Quality Improvement (QI) Program on 5-Year Risk of Diabetes-Related Complications. Diabetes. 68(Supplement_1). 1 indexed citations
4.
Furman, Roy, et al.. (2019). Diabetes INSIDE: Improving Population HbA1c Testing and Targets in Primary Care With a Quality Initiative. Diabetes Care. 43(2). 329–336. 7 indexed citations
5.
Aspry, Karen, Roy Furman, Dean G. Karalis, et al.. (2013). Effect of health information technology interventions on lipid management in clinical practice: A systematic review of randomized controlled trials. Journal of clinical lipidology. 7(6). 546–560. 34 indexed citations
6.
Cohen, Jerome D., Karen Aspry, Alan S. Brown, et al.. (2013). Use of health information technology (HIT) to improve statin adherence and low-density lipoprotein cholesterol goal attainment in high-risk patients: Proceedings from a workshop. Journal of clinical lipidology. 7(6). 573–609. 21 indexed citations
7.
Tanaka, Jacqueline C. & Roy Furman. (1993). Divalent effects on cGMP-activated currents in excised patches from amphibian photoreceptors. The Journal of Membrane Biology. 131(3). 245–256. 15 indexed citations
8.
Furman, Roy & J. C. Tanaka. (1990). Monovalent selectivity of the cyclic guanosine monophosphate-activated ion channel.. The Journal of General Physiology. 96(1). 57–82. 55 indexed citations
9.
Furman, Roy & Jacqueline C. Tanaka. (1989). Photoreceptor channel activation: interaction between cAMP and cGMP. Biochemistry. 28(7). 2785–2788. 22 indexed citations
10.
Tanaka, Jacqueline C., John F. Eccleston, & Roy Furman. (1989). Photoreceptor channel activation by nucleotide derivatives. Biochemistry. 28(7). 2776–2784. 62 indexed citations
11.
Furman, Roy & J. C. Tanaka. (1988). Patch electrode glass composition affects ion channel currents. Biophysical Journal. 53(2). 287–292. 23 indexed citations
12.
Mollman, Joan E., Donna Glover, W. Michael Hogan, & Roy Furman. (1988). Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721. Cancer. 61(11). 2192–2195. 172 indexed citations
13.
Tanaka, J. C., Roy Furman, Walter H. Cobbs, & Paul Müeller. (1987). Incorporation of a retinal rod cGMP-dependent conductance into planar bilayers.. Proceedings of the National Academy of Sciences. 84(3). 724–728. 19 indexed citations
14.
Furman, Roy, J. C. Tanaka, Paul Müeller, & Robert L. Barchi. (1986). Voltage-dependent activation in purified reconstituted sodium channels from rabbit T-tubular membranes.. Proceedings of the National Academy of Sciences. 83(2). 488–492. 26 indexed citations
15.
Mollman, Joan E., Roy Furman, D S Wood, A. Scarpa, & Robert L. Barchi. (1985). Transmembrane calcium movement in 20,25-diazacholesterol myotonia. Experimental Neurology. 90(2). 287–299. 1 indexed citations
16.
Barchi, Robert L., J. C. Tanaka, & Roy Furman. (1984). Molecular characteristics and functional reconstitution of muscle voltage‐sensitive sodium channels. Journal of Cellular Biochemistry. 26(3). 135–146. 20 indexed citations
17.
Furman, Roy & Robert L. Barchi. (1981). 20,25‐diazacholesterol myotonia: An electrophysiological study. Annals of Neurology. 10(3). 251–260. 22 indexed citations
18.
Furman, Roy & Robert L. Barchi. (1978). The pathophysiology of myotonia produced by aromatic carboxylic acids. Annals of Neurology. 4(4). 357–365. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026